Muscle pathology in dysferlin deficiency
- PMID: 12445162
- DOI: 10.1046/j.1365-2990.2002.00417.x
Muscle pathology in dysferlin deficiency
Abstract
Dysferlin deficiency is being increasingly recognized in limb-girdle dystrophy and distal myopathy but its role in the development of muscle pathology is still poorly understood. For this purpose, 26 muscle biopsies from 25 dysferlinopathy patients were analysed by routine histochemistry and by immunohistochemistry with eight different antibodies, and scored for inflammatory response and type of cell infiltrate, fibre degeneration and regeneration, fibre type composition and severity of histopathological changes. In cases with an advanced-stage dystrophic pattern we observed type 1 fibre predominance exceeding 80%, suggesting a selective loss of type 2 fibres or a conversion process. The extent of muscle fibre regeneration and degeneration in dysferlinopathy was intermediate between sarcoglycanopathy and Duchenne dystrophy or myositis, suggesting a rather aggressive course of the disease. An increased inflammatory response was observed in the majority of our patients (16/26), who also showed an active dystrophic pattern. Type and localization of cellular infiltrates suggest that inflammatory reaction is secondary to necrosis. Major histocompatibility complex (MHC) class I molecules were overexpressed in dysferlinopathy, mainly in association with fibre phagocytosis and regeneration; their occasional expression in non-necrotic fibres might represent a marker of ongoing necrosis. Muscle inflammation might be triggered by the structurally altered membrane consequent to dysferlin defect.
Similar articles
-
Ultrastructural changes in dysferlinopathy support defective membrane repair mechanism.J Clin Pathol. 2005 Feb;58(2):190-5. doi: 10.1136/jcp.2004.018978. J Clin Pathol. 2005. PMID: 15677541 Free PMC article.
-
Immunohistochemistry of sarcolemmal membrane-associated proteins in formalin-fixed and paraffin-embedded skeletal muscle tissue: a promising tool for the diagnostic evaluation of common muscular dystrophies.Diagn Pathol. 2017 Feb 20;12(1):19. doi: 10.1186/s13000-017-0610-y. Diagn Pathol. 2017. PMID: 28219397 Free PMC article.
-
Increased dysferlin expression in Duchenne muscular dystrophy.Anal Quant Cytopathol Histpathol. 2014 Feb;36(1):15-22. Anal Quant Cytopathol Histpathol. 2014. PMID: 24902367
-
Dysferlin and the plasma membrane repair in muscular dystrophy.Trends Cell Biol. 2004 Apr;14(4):206-13. doi: 10.1016/j.tcb.2004.03.001. Trends Cell Biol. 2004. PMID: 15066638 Review.
-
Sarcolemmal proteins and the spectrum of limb-girdle muscular dystrophies.Semin Pediatr Neurol. 2002 Jun;9(2):81-99. doi: 10.1053/spen.2002.33795. Semin Pediatr Neurol. 2002. PMID: 12139001 Review.
Cited by
-
Muscle MRI findings in facioscapulohumeral muscular dystrophy.Eur Radiol. 2016 Mar;26(3):693-705. doi: 10.1007/s00330-015-3890-1. Epub 2015 Jun 27. Eur Radiol. 2016. PMID: 26115655
-
Incidental Severe Fatty Degeneration of the Erector Spinae in a Patient with L5-S1 Disc Extrusion Diagnosed with Limb-Girdle Muscular Dystrophy R2 Dysferin-Related.Diagnostics (Basel). 2020 Jul 29;10(8):530. doi: 10.3390/diagnostics10080530. Diagnostics (Basel). 2020. PMID: 32751317 Free PMC article.
-
Muscle Cells Fix Breaches by Orchestrating a Membrane Repair Ballet.J Neuromuscul Dis. 2018;5(1):21-28. doi: 10.3233/JND-170251. J Neuromuscul Dis. 2018. PMID: 29480214 Free PMC article. Review.
-
Quantitation of the calcium and membrane binding properties of the C2 domains of dysferlin.Biophys J. 2014 Jan 21;106(2):382-9. doi: 10.1016/j.bpj.2013.11.4492. Biophys J. 2014. PMID: 24461013 Free PMC article.
-
Muscle membrane repair and inflammatory attack in dysferlinopathy.Skelet Muscle. 2011 Mar 1;1(1):10. doi: 10.1186/2044-5040-1-10. Skelet Muscle. 2011. PMID: 21798087 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials